Retractable Technologies Market Cap 2010-2023 | RVP
Retractable Technologies market cap history and chart from 2010 to 2023. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Retractable Technologies market cap as of April 25, 2024 is $0.03B.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $0.032B | $0.044B |
| Retractable Technologies, Inc. designs, develops, manufactures, and markets innovative patented safety needle devices for the healthcare industry. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $70.359B | 18.83 |
| Becton Dickinson (BDX) | United States | $67.554B | 19.62 |
| West Pharmaceutical Services (WST) | United States | $28.238B | 47.74 |
| Cardinal Health (CAH) | United States | $25.184B | 15.14 |
| Align Technology (ALGN) | United States | $23.613B | 45.61 |
| Cooper (COO) | United States | $17.928B | 27.13 |
| Labcorp (LH) | United States | $17.493B | 14.94 |
| Henry Schein (HSIC) | United States | $9.406B | 16.27 |
| DENTSPLY SIRONA (XRAY) | United States | $6.412B | 16.90 |
| Merit Medical Systems (MMSI) | United States | $4.299B | 24.59 |
| Patterson (PDCO) | United States | $2.346B | 11.24 |
| STAAR Surgical (STAA) | United States | $2.337B | 73.57 |
| CONMED (CNMD) | United States | $2.156B | 19.56 |
| Atrion (ATRI) | United States | $0.747B | 38.46 |
| Lifevantage (LFVN) | United States | $0.079B | 12.85 |
| Pro-Dex (PDEX) | United States | $0.065B | 24.67 |
| Biolase (BIOL) | United States | $0.005B | 0.00 |